Vice President, Clinical Pharmacology @ (February 2020 - April 2022)
Senior Director, DMPK and Clinical Pharmacology @ Peloton Therapeutics a Subsidiary of Merck & Co (July 2019 - February 2020)
Director, DMPK @ (June 2016 - June 2019)
Senior Scientist @ (June 2013 - May 2016)
Investigator Iii and Lab Head @ (April 2006 - March 2013)
Principal Scientist @ Chiron Corporation (January 1999 - April 2006)
Postdoctoral Scholar @ (September 1996 - January 1999)
Keshi Wang Education
Washington University in St. Louis
Doctor of Philosophy (Philosophy, Organic Chemistry)
1991-1996
Nanjing University of Science and Technology
Bachelors
North University of China
Masters
North University of China
Master of Science (Chemical Engineering)
Keshi Wang Summary
Keshi Wang, based in United States, is currently a Senior Vice President, Clinical Pharmacology at Bridgebio. Keshi Wang brings experience from previous roles at Nikang Therapeutics Inc., Peloton Therapeutics a Subsidiary of Merck & Co and Peloton Therapeutics. Keshi Wang holds a 1991 - 1996 Doctor of Philosophy in Philosophy, Organic Chemistry @ Washington University in St. Louis. Keshi Wang has 2 emails on RocketReach.
Looking for a different Keshi Wang?
Find contact details for 700 million professionals.